Prothena Corporation plc (PRTA) États Financiers et Données Historiques

Prothena Corporation plc (PRTA) — Prix $8.24 HealthcareBiotechnology — NASDAQ

Derniers résultats publiés:

États financiers détaillés de Prothena Corporation plc (PRTA): compte de résultat, bilan et tableau de flux de trésorerie. Suivez l'évolution des marges, de la dette, de la liquidité et de la rentabilité d'une année sur l'autre avec jusqu'à 20 ans d'historique.

Résumé de l'Analyse

Prothena Corporation plc a enregistré un chiffre d'affaires de $9.7M sur le dernier exercice, avec un CAGR sur 5 ans de 62.6%.

Marges des 12 derniers mois: marge brute 43.5%, marge opérationnelle -115.1%, marge nette -80.7%.

Au prix actuel de $8.24, PRTA affiche des résultats négatifs (PER non significatif) et un ROE de -14.98%. La capitalisation boursière s'établit à $431M.

Compte de Résultat (10 ans)

Année2016201720182019202020212022202320242025
Revenus$1.1M$27.5M$955000$814000$853000$200.6M$53.9M$91.4M$135.2M$9.7M
Coût des Ventes$119.5M$134.5M$101.2M$50.8M$74.9M0000$3.7M
Marge Brute-$118.5M-$107.0M-$100.2M-$50.0M-$74.0M$200.6M$53.9M$91.4M$135.2M$6.0M
R&D$119.5M$134.5M$101.2M$50.8M$75.1M$82.3M$135.6M$220.6M$222.5M$134.9M
Frais Généraux$41.1M$48.2M$42.5M$35.7M$38.7M$46.3M$49.9M$61.8M$67.2M$59.4M
Charges Opérationnelles$160.6M$182.8M$143.7M$35.7M$38.7M$128.6M$185.5M$282.4M$289.7M$190.5M
Résultat Opérationnel-$159.5M-$155.3M-$158.9M-$85.7M-$112.7M$72.0M-$131.6M-$191.0M-$154.6M-$184.6M
EBITDA-$156.5M-$152.2M-$152.9M-$84.2M-$111.2M$73.0M-$124.9M-$159.6M-$128.0M-$197.1M
Charges d'Intérêt$863000$3.7M$3.7M0000000
Résultat Avant Impôts-$159.0M-$157.6M-$156.1M-$77.3M-$110.9M$71.9M-$125.6M-$160.5M-$128.9M-$200.8M
Impôts$1.1M-$4.4M-$470000$379000$282999$4.9M-$8.7M-$13.5M-$6.6M$43.3M
Résultat Net-$160.1M-$153.2M-$155.6M-$77.7M-$111.1M$67.0M-$116.9M-$147.0M-$122.3M-$244.1M
BPA$-4.66$-4.07$-3.93$-1.95$-2.78$1.51$-2.47$-2.76$-2.27$-4.53
BPA Dilué$-4.66$-4.07$-3.93$-1.95$-2.78$1.38$-2.47$-2.76$-2.27$-4.53
Actions en Circulation (Diluées)$34.4M$37.7M$39.6M$39.9M$39.9M$48.5M$47.4M$53.2M$53.8M$53.8M

Compte de Résultat (Trimestriel)

Année2025-Q32025-Q42026-Q12026-Q2
Revenus$2.4M$21000$51.1M$1.0M
Marge Brute-$26.5M-$921000$50.2M$1.0M
Résultat Opérationnel-$40.2M-$27.2M$25.8M-$21.1M
EBITDA-$35.9M-$20.6M$33.6M-$18.2M
Résultat Net-$36.5M-$21.6M$32.7M-$18.6M
BPA$-0.68$-0.40$0.61$-0.36
BPA Dilué$-0.68$-0.40$0.60$-0.36

Bilan (10 ans)

Année2016201720182019202020212022202320242025
Trésorerie$386.9M$417.6M$427.7M$375.7M$295.4M$579.1M$710.4M$618.8M$471.4M$307.5M
Placements à Court Terme0000000000
Créances$178000$240000$2000$68000$15000$13000$62000$5.2M00
Stocks-$178000-$24000000000000
Actifs Courants$391.4M$426.3M$431.4M$378.4M$299.3M$584.8M$719.1M$639.3M$485.4M$315.2M
Immobilisations Corporelles$56.5M$55.0M$52.8M$27.1M$20.4M$14.1M$8.0M$16.0M$13.8M$10.3M
Goodwill0000000000
Actifs Incorporels0000000000
Actifs Totaux$460.0M$496.3M$498.8M$419.3M$333.0M$609.4M$758.0M$696.4M$547.1M$326.8M
Dettes Fournisseurs$13.1M$13.6M$1.5M$1.2M$4.1M$3.7M$9.3M$25.4M$7.8M$5.9M
Dette à Court Terme000000000$2.9M
Passifs Courants$41.1M$37.4M$14.9M$17.7M$25.8M$33.5M$50.1M$56.9M$48.5M$40.8M
Dette à Long Terme000000000$5.5M
Passifs Totaux$94.6M$89.1M$175.8M$146.3M$149.0M$143.3M$136.0M$135.0M$60.2M$46.3M
Réserves-$289.2M-$442.4M-$598.0M-$671.9M-$783.0M-$716.1M-$833.0M-$980.0M-$1.10B-$1.35B
Capitaux Propres$365.4M$407.2M$323.0M$272.9M$184.0M$466.0M$622.0M$561.4M$486.9M$280.5M
Dette Totale$51.3M$52.2M$51.5M$22.9M$17.8M$12.3M$6.5M$11.8M$10.8M$13.9M
Dette Nette-$335.6M-$365.4M-$376.1M-$352.8M-$277.5M-$566.8M-$703.9M-$607.0M-$460.5M-$293.7M
Fonds de Roulement$350.3M$389.0M$416.5M$360.7M$273.4M$551.4M$669.0M$582.4M$436.9M$274.4M

Bilan (Trimestriel)

Année2025-Q32025-Q42026-Q12026-Q2
Trésorerie$330.8M$307.5M$329.5M$288.2M
Actifs Totaux$352.6M$326.8M$349.9M$302.6M
Passifs Totaux$57.6M$46.3M$37.3M$15.7M
Capitaux Propres$295.0M$280.5M$312.6M$286.9M
Dette Totale$9.1M$13.9M$7.7M$7.0M

Tableau de Flux (10 ans)

Année2016201720182019202020212022202320242025
Résultat Net-$160.1M-$153.2M-$155.6M-$77.7M-$111.1M$67.0M-$116.9M-$147.0M-$122.3M-$244.1M
Amortissements$2.4M$3.1M$3.2M$6.8M$1.5M$1.1M$744000$928000$893000$895000
Stock-based Compensation$24.9M$26.8M$27.0M$23.6M$22.0M$24.7M$31.3M$40.9M$46.0M$37.6M
Variation du BFR$18.9M-$7.2M$94.5M-$4.4M$3.5M-$10.4M-$18.8M-$20.5M-$67.9M-$4.2M
Cash Flow Opérationnel-$117.3M-$131.2M-$28.3M-$53.0M-$80.4M$92.6M-$108.8M-$133.9M-$150.1M-$163.6M
CapEx-$16.6M-$3.6M-$1.8M-$555000-$196000-$575000-$464000-$2.8M-$298000-$138000
Acquisitions0$105000$390000000000
Rachat d'Actions00000000-$3530000
Dividendes Payés0000000000
Free Cash Flow-$133.9M-$134.8M-$30.0M-$53.5M-$80.6M$92.0M-$109.3M-$136.7M-$150.3M-$163.7M

Tableau de Flux (Trimestriel)

Année2025-Q32025-Q42026-Q12026-Q2
Cash Flow Opérationnel-$40.6M-$23.3M$28.9M-$25.0M
CapEx-$1000000-$652000
Free Cash Flow-$40.6M-$23.3M$28.9M-$25.7M
Dividendes Payés0000
Stock-based Compensation$7.2M$7.1M$6.9M$7.9M

Croissance et Marges (10 ans)

Année2016201720182019202020212022202320242025
Croissance Revenus (annuelle)+2508.4%-96.5%-14.8%+4.8%+23414.3%-73.1%+69.5%+47.9%-92.8%
Croissance Résultat Net (annuelle)+4.3%-1.6%+50.1%-43.1%+160.3%-274.6%-25.7%+16.8%-99.6%
Croissance BPA (annuelle)+12.7%+3.4%+50.4%-42.6%+154.3%-263.6%-11.7%+17.8%-99.6%
Variation Actions (annuelle)+9.6%+5.1%+0.8%+0.1%+21.4%-2.3%+12.3%+1.0%+0.1%
Croissance FCF (annuelle)-0.7%+77.7%-78.2%-50.5%+214.2%-218.7%-25.1%-10.0%-8.9%
Marge Brute-11230.2%-388.9%-10495.1%-6145.2%-8678.9%100.0%100.0%100.0%100.0%61.8%
Marge Opérationnelle-15121.8%-564.2%-16634.0%-10527.9%-13216.2%35.9%-244.1%-209.1%-114.4%-1905.8%
Marge EBITDA-14837.6%-553.0%-16010.4%-10343.2%-13038.7%36.4%-231.6%-174.6%-94.7%-2035.6%
Marge Nette-15176.1%-556.8%-16297.9%-9542.6%-13029.8%33.4%-217.0%-160.9%-90.5%-2520.6%
Marge FCF-12693.2%-489.9%-3146.0%-6575.4%-9444.1%45.9%-202.7%-149.6%-111.2%-1690.6%
Taux d'Imposition Effectif-0.7%2.8%0.3%-0.5%-0.3%6.9%6.9%8.4%5.1%-21.5%

Données par Action (10 ans)

Année2016201720182019202020212022202320242025
FCF par Action$-3.90$-3.58$-0.76$-1.34$-2.02$1.90$-2.31$-2.57$-2.80$-3.04
Dividende par Action$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Actions en Circulation (Basiques)$34.4M$37.7M$39.6M$39.9M$39.9M$44.2M$47.4M$53.2M$53.8M$53.8M

Quoi regarder en Biotech

La plupart des petites biotechs perdent de l'argent. Les analyser avec le P/E n'a aucun sens — regardez cash et pipeline.

Rentabilité

Rentabilité des capitaux propres-14.98%
Rentabilité du capital investi-21.36%
Rentabilité des actifs-14.54%
Marge brute43.52%
Marge opérationnelle-115.09%
Marge nette-80.67%

Santé financière

Dette / Capitaux propres0.02
Ratio de liquidité25.05
Piotroski F-Score1
Altman Z-Score0.06

Ratios Clés (10 ans)

Année2016201720182019202020212022202320242025
PER-10.56-9.21-2.62-8.12-4.3232.72-24.39-13.17-6.10-2.11
P/B4.623.471.262.312.614.694.593.441.531.83
P/V1601.6451.30426.66775.59561.9910.8952.9421.175.5153.08
Marge Brute-11230.2%-388.9%-10495.1%-6145.2%-8678.9%100.0%100.0%100.0%100.0%61.8%
Marge Opérationnelle-15121.8%-564.2%-16634.0%-10527.9%-13216.2%35.9%-244.1%-209.1%-114.4%-1905.8%
Marge Nette-15176.1%-556.8%-16297.9%-9542.6%-13029.8%33.4%-217.0%-160.9%-90.5%-2520.6%

Entreprises liées: BCYC · CRVS · FDMT · GOSS · KALV · NMRA · OLMA

Explorer le secteur: Healthcare · Biotechnology

Plus de sections de PRTA: Vue d'ensemble · Valorisation · Statistiques · Estimations · Technique · Actionnariat · Actualités · Événements

Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions